chr16-1445133-G-GC
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001287.6(CLCN7):c.*1497_*1498insG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0287 in 152,258 control chromosomes in the GnomAD database, including 83 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.029 ( 83 hom., cov: 32)
Exomes 𝑓: 0.063 ( 0 hom. )
Consequence
CLCN7
NM_001287.6 3_prime_UTR
NM_001287.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -5.12
Genes affected
CLCN7 (HGNC:2025): (chloride voltage-gated channel 7) The product of this gene belongs to the CLC chloride channel family of proteins. Chloride channels play important roles in the plasma membrane and in intracellular organelles. This gene encodes chloride channel 7. Defects in this gene are the cause of osteopetrosis autosomal recessive type 4 (OPTB4), also called infantile malignant osteopetrosis type 2 as well as the cause of autosomal dominant osteopetrosis type 2 (OPTA2), also called autosomal dominant Albers-Schonberg disease or marble disease autosoml dominant. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. OPTA2 is the most common form of osteopetrosis, occurring in adolescence or adulthood. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0287 (4372/152226) while in subpopulation NFE AF= 0.0419 (2849/67988). AF 95% confidence interval is 0.0406. There are 83 homozygotes in gnomad4. There are 2038 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 83 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLCN7 | NM_001287.6 | c.*1497_*1498insG | 3_prime_UTR_variant | 25/25 | ENST00000382745.9 | ||
CLCN7 | NM_001114331.3 | c.*1497_*1498insG | 3_prime_UTR_variant | 24/24 | |||
CLCN7 | XM_011522354.2 | c.*1497_*1498insG | 3_prime_UTR_variant | 25/25 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLCN7 | ENST00000382745.9 | c.*1497_*1498insG | 3_prime_UTR_variant | 25/25 | 1 | NM_001287.6 | P1 | ||
CLCN7 | ENST00000563642.6 | n.3984_3985insG | non_coding_transcript_exon_variant | 9/9 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0288 AC: 4376AN: 152110Hom.: 83 Cov.: 32
GnomAD3 genomes
AF:
AC:
4376
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0625 AC: 2AN: 32Hom.: 0 Cov.: 0 AF XY: 0.0500 AC XY: 1AN XY: 20
GnomAD4 exome
AF:
AC:
2
AN:
32
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
20
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0287 AC: 4372AN: 152226Hom.: 83 Cov.: 32 AF XY: 0.0274 AC XY: 2038AN XY: 74424
GnomAD4 genome
AF:
AC:
4372
AN:
152226
Hom.:
Cov.:
32
AF XY:
AC XY:
2038
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Osteopetrosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at